• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Medical Cannabis Market Share

    ID: MRFR/HC/6896-CR
    146 Pages
    Rahul Gotadki
    August 2021

    Medical Cannabis Market Research Report By Application (Pain Management, Neurological Disorders, Cancer Treatment, Mental Health Disorders, Inflammatory Conditions), By Product Type (Flower, Oils, Tinctures, Edibles, Topicals), By Distribution Channel (Pharmacies, Online Stores, Dispensaries), By Formulation (Cannabinoid-Based, Herbal-Based, Synthetic) and By Regional (North America, Europe, So...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Medical Cannabis Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Share

    Medical Cannabis Market Share Analysis

    Many people around the world are dealing with chronic diseases like chemotherapy-induced nausea and vomiting, epilepsy, spasticity linked to multiple sclerosis or spinal cord injury, fibromyalgia, and glaucoma. As these conditions become more widespread, there is a growing need for medications based on cannabis because there is substantial evidence suggesting that cannabis can be an effective treatment for various diseases. Furthermore, using medical cannabis has shown benefits in improving the outlook for certain diseases. For instance, Dronabinol (Marinol), a THC-based gelatin capsule developed by Solvay Pharmaceuticals in Belgium, has received approval from the US FDA for treating nausea and vomiting caused by cancer chemotherapy. It is also sanctioned for patients with AIDS experiencing weight loss and poor appetite. Another example is Cesamet (nabilone), initially created by Eli Lilly and Company in the US, which is prescribed for nausea and vomiting related to cancer chemotherapy. According to a study published in May 2019 in the Lancet Oncology journal, the number of patients requiring chemotherapy is estimated to rise by 53% from 2018 to 2040. A study published in June 2020 in the Yale Journal of Biology and Medicine focused on testing cannabis flower for its potential in treating depression symptoms. The findings indicated that many patients using cannabis experienced antidepressant effects. While there is moderate or low-quality evidence for cannabinoids being effective in treating other chronic conditions, the increasing number of studies conducted so far suggests that the rising prevalence of chronic diseases will significantly impact the growth of the market. In simpler terms, a lot of people worldwide are dealing with long-term health issues like nausea from chemotherapy, epilepsy, and other conditions. As these health problems become more common, there is a greater demand for medicines made from cannabis because evidence shows that cannabis can help treat these diseases. Additionally, using medical cannabis has shown positive effects in improving the outlook for certain diseases. For example, there are medications like Marinol, a capsule containing THC, approved to treat nausea and vomiting caused by cancer chemotherapy. Another medication, Cesamet, is prescribed for similar issues related to cancer treatment. A study predicts that more people will need chemotherapy in the coming years. A study also found that using cannabis may help with symptoms of depression. While the evidence for cannabis treating other chronic conditions is not very strong, the growing number of studies suggests that the increasing number of people with chronic diseases will have a big impact on the growth of the cannabis medicine market.

    Market Summary

    As per Market Research Future Analysis, the Medical Cannabis Market was valued at 28.59 USD Billion in 2024 and is projected to grow to 0.00 USD Billion by 2035, with a CAGR of 0.00% from 2025 to 2035. The market is driven by increasing legalization, rising prevalence of chronic diseases, and significant investments in cannabis research.

    Key Market Trends & Highlights

    The Global Medical Cannabis Market is experiencing rapid growth due to evolving regulations and increasing consumer acceptance.

    • Market Size in 2024: 28.59 USD Billion; projected to reach 0.00 USD Billion by 2035. Pain Management segment valued at 6.0 USD Billion in 2024; expected to grow to 15.0 USD Billion by 2035. North America leads the market with a valuation of 10.0 USD Billion in 2024; projected to reach 0.00 USD Billion by 2035. Investment in cannabis research has increased by over 300% in the last decade.

    Market Size & Forecast

    2025 Market Size USD 28.59 Billion
    2035 Market Size USD 0.00 Billion
    CAGR (2025-2035) 0.00%
    Largest Regional Market Share in 2024 North America

    Major Players

    <p>Trulieve, Aphria, Tilray, Columbia Care, Harvest Health and Recreation, Aurora Cannabis, MedMen Enterprises, Organigram Holdings, Green Thumb Industries, Charlotte's Web Holdings, GW Pharmaceuticals, Cresco Labs, Canopy Growth Corporation, Curaleaf, Cronos Group</p>

    Market Trends

    The Global Medical Cannabis Market is expanding at a rapid pace due to the growing acceptance of cannabis for medical purposes. The therapeutic potential of cannabis is being acknowledged by governments in a variety of regions, resulting in regulatory changes that endorse its use. 

    This change is a significant market driver, as an increasing number of countries are enacting legislation that permits the cultivation, production, and distribution of medical cannabis.

    Furthermore, there is an increase in research that is designed to investigate the effectiveness of cannabis in the treatment of a diverse array of medical conditions, such as chronic pain, epilepsy, and cancer-related symptoms. This increasing body of evidence is further motivating healthcare professionals and patients to accept cannabis as a viable treatment option. 

    In this market, there are opportunities to investigate the development of novel cannabis-based pharmaceuticals and delivery methods that can improve patient compliance and accessibility.

    There is potential for partnerships between pharmaceutical firms and cannabis companies to develop innovative products as research continues to validate the benefits of medical cannabis. Additionally, the expansion of e-commerce platforms for the distribution of medicinal cannabis has the potential to reach a broader audience. 

    In recent years, there has been a noticeable trend toward the demand for personalized medicine, which is consistent with the capacity of cannabis products to be customized to meet the unique requirements and conditions of each individual.

    The market is also witnessing a surge in consumer awareness regarding the differences between THC and CBD, leading to informed choices in product selection. As the perception of cannabis continues to shift globally, investment in education and healthcare provider training will be essential to support this evolving market landscape. 

    This combination of changing regulations, research advancements, and shifting consumer preferences is shaping the future of the Global Medical Cannabis Market.

     

    <p>The evolving landscape of medical cannabis regulation suggests a growing acceptance and integration of cannabis-based therapies within healthcare systems, potentially enhancing patient access to alternative treatment options.</p>

    U.S. Department of Health and Human Services

    Medical Cannabis Market Market Drivers

    Increasing Acceptance of Medical Cannabis

    The growing acceptance of medical cannabis among healthcare professionals and patients is a pivotal driver of the Global Medical Cannabis Market Industry. As more studies emerge highlighting the therapeutic benefits of cannabis for conditions such as chronic pain, epilepsy, and multiple sclerosis, healthcare providers are increasingly recommending its use. This shift in perception is reflected in the projected market value, which is expected to reach 18.7 USD Billion in 2024. The increasing number of states and countries legalizing medical cannabis further supports this trend, suggesting a robust future for the industry.

    Market Segment Insights

    Medical Cannabis Market Application Insights

    <p>The Global Medical Cannabis Market is witnessing significant expansion within the Application segment, projected to reach a valuation of 18.74 USD Billion in 2024. By 2035, this market is expected to surmount 50.0 USD Billion, influenced by rising acceptance of cannabis in clinical settings and evolving regulatory landscapes across countries.&nbsp;</p>

    <p>Among the various applications, <a href="https://www.marketresearchfuture.com/reports/pain-management-market-5975'">Pain Management </a>holds a majority share, currently valued at 6.0 USD Billion in 2024 and anticipated to rise to 15.0 USD Billion by 2035, highlighting the increasing reliance on cannabis for chronic pain relief, a significant healthcare challenge globally.</p>

    <p>Neurological Disorders, valued at 4.5 USD Billion in 2024, is also a notable contributor, growing to 12.0 USD Billion by 2035, as cannabis offers potential therapeutic benefits for conditions such as epilepsy and multiple sclerosis. Cancer Treatment, Mental Health Disorders, and Inflammatory Conditions are also vital areas of focus in the Global Medical Cannabis Market.&nbsp;</p>

    Medical Cannabis Market Product Type Insights

    <p>The Global Medical Cannabis Market revenue reflects a dynamic landscape, with various product types that cater to diverse patient needs. As the market progresses toward a valuation of 18.74 USD Billion in 2024, the segmentation showcases a range of offerings, including Flower, Oils, Tinctures, Edibles, and Topicals.&nbsp;</p>

    <p>Each of these product types plays a crucial role in meeting the evolving preferences of consumers. The flower segment, often seen as the traditional choice, remains a significant contributor due to its wide acceptance and familiar usage among patients.</p>

    <p>Oils and tinctures are gaining traction for their concentrated forms and ease of use, appealing especially to those seeking precise dosages. Edibles are increasingly popular for their discretion and diverse options, aligning with a broader trend of integrating cannabis into everyday products. Topicals provide localized relief, appealing to those who prefer to avoid systemic effects.&nbsp;</p>

    Medical Cannabis Market Distribution Channel Insights

    <p>The Global Medical Cannabis Market revenue is poised for substantial growth, forecasted to reach 18.74 billion USD by 2024 and continue its ascent towards 50.0 billion USD by 2035. Within the realm of distribution channels, Pharmacies, Online Stores, and Dispensaries play critical roles in ensuring accessibility for patients.&nbsp;</p>

    <p>Pharmacies often serve as the most traditional and regulated avenues for obtaining medical cannabis, thus instilling consumer trust and providing essential information through qualified professionals.</p>

    <p>Online Stores have rapidly gained traction, driven by increasing convenience and the ability to reach a broader audience, reflecting changing consumer preferences for e-commerce. Meanwhile, Dispensaries provide a personalized shopping experience, allowing consumers to engage directly with knowledgeable staff, which enhances customer satisfaction and education about various products.</p>

    Medical Cannabis Market Formulation Insights

    <p>The Global Medical Cannabis Market is projected to reach a valuation of 18.74 USD Billion by 2024, showcasing significant growth potential driven by increased legalization and demand for therapeutic applications of cannabis. The Formulation segment plays a critical role within this market, encompassing various types like Cannabinoid-Based, Herbal-Based, and Synthetic formulations.&nbsp;</p>

    <p>Cannabinoid-based products are notably significant due to their efficacy and wide acceptance in managing chronic pain, epilepsy, and other disorders, marking a dominant presence in the market.</p>

    <p>Herbal-based formulations leverage the natural properties of cannabis and are increasingly preferred due to a rising trend in holistic and alternative medicines, offering diverse therapeutic benefits without synthetic additives. Meanwhile, Synthetic formulations cater to specific medical needs and often feature in clinical settings, providing controlled dosing options that appeal to both healthcare providers and patients alike.&nbsp;</p>

    Get more detailed insights about Medical Cannabis Market Research Report - Forecast till 2035

    Regional Insights

    The Global Medical Cannabis Market is poised for significant growth, with North America leading the charge as the most substantial contributor, valued at 10.0 USD Billion in 2024 and projected to reach 25.68 USD Billion by 2035. This region's dominance stems from favorable regulatory environments and rising acceptance of cannabis for medical use. 

    Europe follows with a valuation of 4.5 USD Billion in 2024, advancing to 11.57 USD Billion in 2035, fueled by increasing awareness regarding the therapeutic benefits of medical cannabis.

    The Asia Pacific (APAC) region, although smaller, shows promising growth potential, with a market size of 2.5 USD Billion in 2024, poised to reach 6.55 USD Billion by 2035, driven by changing legislation and growing research initiatives. South America, valued at 1.5 USD Billion in 2024, is expected to evolve into a notable market with 3.93 USD Billion by 2035 as legalization efforts gain traction.

    Meanwhile, the Middle East and Africa (MEA) market, starting from 0.74 USD Billion in 2024 and reaching 2.27 USD Billion by 2035, reflects increasing interest in medical cannabis amidst evolving regulatory frameworks and demand for alternative treatments. 

    The overall landscape highlights significant opportunities for market growth driven by changes in legislation, cultural acceptance, and continued research into the benefits of medical cannabis across these regions.

    Medical Cannabis Market Region

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Global Medical Cannabis Market has witnessed significant growth and diversification, driven by an increasing acceptance of cannabis for medicinal purposes across various jurisdictions. This market is characterized by a mix of established players and emerging companies that are working to capitalize on the expanding consumer base and evolving regulatory landscape. 

    Competitive insights reveal a dynamic environment where companies strive to innovate through product development and differentiation while navigating stringent compliance parameters.

    The competitive landscape is influenced by factors such as research and development capabilities, distribution networks, and partnerships, which play crucial roles in shaping market positioning and consumer engagement. As the market matures, companies are increasingly focusing on quality assurance and patient education, positioning themselves as trustworthy sources of medical cannabis products.

    Trulieve has positioned itself as a strong contender in the Global Medical Cannabis Market, leveraging its extensive cultivation and retail footprint to gain market share. With a robust product catalog that includes various forms of cannabis, such as oils, capsules, and edibles, Trulieve successfully caters to diverse patient needs. 

    The company’s strategic presence in multiple regions allows it to optimize its distribution channels and connect with a vast consumer base. Known for its commitment to high-quality products and customer service, Trulieve's strengths lie in its operational efficiency and a solid reputation built on reliability.

    This approach not only solidifies customer loyalty but also enhances its brand value within the global market, allowing it to maintain a competitive edge amid evolving industry dynamics. Aphria is another key player in the Global Medical Cannabis Market, recognized for its innovative approach and a wide range of products tailored to the medical sector. 

    The company offers an extensive lineup of cannabis oils, capsules, and dried flower products, catering to the specific therapeutic needs of patients around the globe. Aphria's market presence is bolstered by strategic partnerships and acquisitions that enhance its operational capabilities and expand its reach.

    This includes collaborations aimed at advancing research on cannabis applications in medicine, which reinforces its commitment to quality and efficacy. Additionally, Aphria's strengths lie in its robust supply chain management, adherence to regulatory standards, and ongoing focus on sustainability. As the global market continues to evolve, Aphria maintains a strong position through its dedication to innovation and effective governance practices.

    Key Companies in the Medical Cannabis Market market include

    Industry Developments

    • Q1 2024: New York Increases Cannabis Retail Licenses and Launches Grant Program for Impacted Business Owners New York announced it will increase the number of Conditional Adult-Use Retail Dispensary (CAURD) licenses from 275 to over 625 in 2025 and launch a new grant program awarding up to $30,000 to CAURD retailers who have been impacted by marijuana-related convictions.
    • Q1 2024: Over 300 Cannabis Dispensaries Open in New York Under CAURD License As of March 2024, more than 300 dispensaries have opened in New York State under the Conditional Adult-Use Retail Dispensary (CAURD) license, reflecting rapid expansion in the state's regulated cannabis market.

    Future Outlook

    Medical Cannabis Market Future Outlook

    <p>The Global Medical Cannabis Market is projected to grow at a 9.33% CAGR from 2025 to 2035, driven by increasing legalization, expanding research, and rising consumer demand.</p>

    New opportunities lie in:

    • <p>Develop innovative delivery systems for medical cannabis to enhance patient compliance. Invest in clinical trials to validate therapeutic benefits and expand product offerings. Leverage telemedicine platforms to improve patient access to medical cannabis consultations.</p>

    <p>By 2035, the market is expected to be robust, reflecting substantial growth and innovation.</p>

    Market Segmentation

    Medical Cannabis Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Medical Cannabis Market Application Outlook

    • Pain Management
    • Neurological Disorders
    • Cancer Treatment
    • Mental Health Disorders
    • Inflammatory Conditions

    Medical Cannabis Market Formulation Outlook

    • Cannabinoid-Based
    • Herbal-Based
    • Synthetic

    Medical Cannabis Market Product Type Outlook

    • Flower
    • Oils
    • Tinctures
    • Edibles
    • Topicals

    Medical Cannabis Market Distribution Channel Outlook

    • Pharmacies
    • Online Stores
    • Dispensaries

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 202317.15(USD Billion)
    MARKET SIZE 202418.74(USD Billion)
    MARKET SIZE 203550.0(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR)0.00% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2023
    MARKET FORECAST UNITSUSD Billion
    KEY COMPANIES PROFILEDTrulieve, Aphria, Tilray, Columbia Care, Harvest Health and Recreation, Aurora Cannabis, MedMen Enterprises, Organigram Holdings, Green Thumb Industries, Charlotte's Web Holdings, GW Pharmaceuticals, Cresco Labs, Canopy Growth Corporation, Curaleaf, Cronos Group
    SEGMENTS COVEREDApplication, Product Type, Distribution Channel, Formulation, Regional
    KEY MARKET OPPORTUNITIESRising legalization trends, Expanding therapeutic applications, Growing elderly population, Increased investment in R&D, Development of innovative delivery methods
    KEY MARKET DYNAMICSRegulatory approval processes, Increasing patient acceptance, Rising prevalence of chronic diseases, Expanding medicinal product portfolio, Growing investment in research
    COUNTRIES COVEREDNorth America, Europe, APAC, South America, MEA
    Market Size 202428.59
    Market Size 202532.74
    Base Year2024
    Market Forecast Period2025 - 2035

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the projected market size of the Global Medical Cannabis Market in 2024?

    The Global Medical Cannabis Market is expected to be valued at 18.74 USD billion in 2024.

    What is the expected market size of the Global Medical Cannabis Market by 2035?

    By 2035, the Global Medical Cannabis Market is anticipated to reach a valuation of 50.0 USD billion.

    What is the Compound Annual Growth Rate (CAGR) for the Global Medical Cannabis Market from 2025 to 2035?

    The Global Medical Cannabis Market is projected to grow at a CAGR of 9.33% from 2025 to 2035.

    Which region will dominate the Global Medical Cannabis Market in 2024?

    North America is expected to dominate the Global Medical Cannabis Market with a valuation of 10.0 USD billion in 2024.

    What is the estimated market size for Pain Management in the Global Medical Cannabis Market by 2035?

    The market size for Pain Management is projected to reach 15.0 USD billion by 2035.

    Which key player had a market size of 6.0 USD billion in Pain Management by 2024?

    In 2024, the market size for Pain Management within the Global Medical Cannabis Market is estimated to be 6.0 USD billion.

    What market size is anticipated for the Neurological Disorders application by 2035?

    The Neurological Disorders application is expected to be valued at 12.0 USD billion by 2035.

    What is the expected market size for the Cancer Treatment application in 2024?

    The Cancer Treatment application is projected to have a market size of 3.0 USD billion in 2024.

    Which region is expected to experience significant growth from 2024 to 2035?

    The North America region is projected to witness significant growth, expanding from 10.0 USD billion in 2024 to 25.68 USD billion by 2035.

    How much is the Inflammatory Conditions application expected to be worth in 2035?

    The Inflammatory Conditions application is projected to reach 7.0 USD billion by 2035.

    1. --- "Table of Contents
    2. Executive Summary 
      1. Market Overview 
      2. Key Findings 
      3. Market Segmentation 
      4. Competitive Landscape 
      5. Challenges and Opportunities 
      6. Future Outlook 
    3. Market Introduction 
      1. Definition 
      2. Scope of the Study 
        1. Research Objective 
        2. Assumption 
        3. Limitations 
    4. Research Methodology 
      1. Overview 
      2. Data Mining 
      3. Secondary Research 
      4. Primary Research 
        1. Primary Interviews and Information Gathering Process 
        2. Breakdown of Primary Respondents 
      5. Forecasting Model 
      6. Market Size Estimation 
        1. Bottom-up Approach 
        2. Top-Down Approach 
      7. Data Triangulation 
      8. Validation 
    5. MARKET DYNAMICS 
      1. Overview 
      2. Drivers 
      3. Restraints 
      4. Opportunities 
    6. MARKET FACTOR ANALYSIS 
      1. Value chain Analysis 
      2. Porter's Five Forces Analysis 
        1. Bargaining Power of Suppliers 
        2. Bargaining Power of Buyers 
        3. Threat of New Entrants 
        4. Threat of Substitutes 
        5. Intensity of Rivalry 
      3. COVID-19 Impact Analysis 
        1. Market Impact Analysis 
        2. Regional Impact 
        3. Opportunity and Threat Analysis 
    7. MEDICAL CANNABIS MARKET, BY APPLICATION (USD BILLION) 
      1. Pain Management 
      2. Neurological Disorders 
      3. Cancer Treatment 
      4. Mental Health Disorders 
      5. Inflammatory Conditions 
    8. MEDICAL CANNABIS MARKET, BY PRODUCT TYPE (USD BILLION) 
      1. Flower 
      2. Oils 
      3. Tinctures 
      4. Edibles 
      5. Topicals 
    9. MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL (USD BILLION) 
      1. Pharmacies 
      2. Online Stores 
      3. Dispensaries 
    10. MEDICAL CANNABIS MARKET, BY FORMULATION (USD BILLION) 
      1. Cannabinoid-Based 
      2. Herbal-Based 
      3. Synthetic 
    11. MEDICAL CANNABIS MARKET, BY REGIONAL (USD BILLION) 
      1. North America 
        1. US 
        2. Canada 
      2. Europe 
        1. Germany 
        2. UK 
        3. France 
        4. Russia 
        5. Italy 
        6. Spain 
        7. Rest of Europe 
      3. APAC 
        1. China 
        2. India 
        3. Japan 
        4. South Korea 
        5. Malaysia 
        6. Thailand 
        7. Indonesia 
        8. Rest of APAC 
      4. South America 
        1. Brazil 
        2. Mexico 
        3. Argentina 
        4. Rest of South America 
      5. MEA 
        1. GCC Countries 
        2. South Africa 
        3. Rest of MEA 
    12. Competitive Landscape 
      1. Overview 
      2. Competitive Analysis 
      3. Market share Analysis 
      4. Major Growth Strategy in the Medical Cannabis Market 
      5. Competitive Benchmarking 
      6. Leading Players in Terms of Number of Developments in the Medical Cannabis Market 
      7. Key developments and growth strategies 
        1. New Product Launch/Service Deployment 
        2. Merger & Acquisitions 
        3. Joint Ventures 
      8. Major Players Financial Matrix 
        1. Sales and Operating Income 
        2. Major Players R&D Expenditure. 2023 
    13. COMPANY PROFILES 
      1. Trulieve 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      2. Aphria 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      3. Tilray 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      4. Columbia Care 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      5. Harvest Health and Recreation 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      6. Aurora Cannabis 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      7. MedMen Enterprises 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      8. Organigram Holdings 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      9. Green Thumb Industries 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      10. Charlotte's Web Holdings 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      11. GW Pharmaceuticals 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      12. Cresco Labs 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      13. Canopy Growth Corporation 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      14. Curaleaf 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
      15. Cronos Group 
        1. Financial Overview 
        2. Products Offered 
        3. Key Developments 
        4. SWOT Analysis 
        5. Key Strategies 
    14. APPENDIX 
      1. References 
      2. Related Reports 
    15. List of Tables and Figures
      1. LIST OF TABLES
      2. TABLE 1. LIST OF ASSUMPTIONS 
      3. TABLE 2. NORTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      4. TABLE 3. NORTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      5. TABLE 4. NORTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      6. TABLE 5. NORTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      7. TABLE 6. NORTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      8. TABLE 7. US MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      9. TABLE 8. US MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      10. TABLE 9. US MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      11. TABLE 10. US MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      12. TABLE 11. US MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      13. TABLE 12. CANADA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      14. TABLE 13. CANADA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      15. TABLE 14. CANADA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      16. TABLE 15. CANADA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      17. TABLE 16. CANADA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      18. TABLE 17. EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      19. TABLE 18. EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      20. TABLE 19. EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      21. TABLE 20. EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      22. TABLE 21. EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      23. TABLE 22. GERMANY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      24. TABLE 23. GERMANY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      25. TABLE 24. GERMANY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      26. TABLE 25. GERMANY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      27. TABLE 26. GERMANY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      28. TABLE 27. UK MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      29. TABLE 28. UK MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      30. TABLE 29. UK MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      31. TABLE 30. UK MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      32. TABLE 31. UK MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      33. TABLE 32. FRANCE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      34. TABLE 33. FRANCE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      35. TABLE 34. FRANCE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      36. TABLE 35. FRANCE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      37. TABLE 36. FRANCE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      38. TABLE 37. RUSSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      39. TABLE 38. RUSSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      40. TABLE 39. RUSSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      41. TABLE 40. RUSSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      42. TABLE 41. RUSSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      43. TABLE 42. ITALY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      44. TABLE 43. ITALY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      45. TABLE 44. ITALY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      46. TABLE 45. ITALY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      47. TABLE 46. ITALY MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      48. TABLE 47. SPAIN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      49. TABLE 48. SPAIN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      50. TABLE 49. SPAIN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      51. TABLE 50. SPAIN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      52. TABLE 51. SPAIN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      53. TABLE 52. REST OF EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      54. TABLE 53. REST OF EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      55. TABLE 54. REST OF EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      56. TABLE 55. REST OF EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      57. TABLE 56. REST OF EUROPE MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      58. TABLE 57. APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      59. TABLE 58. APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      60. TABLE 59. APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      61. TABLE 60. APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      62. TABLE 61. APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      63. TABLE 62. CHINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      64. TABLE 63. CHINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      65. TABLE 64. CHINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      66. TABLE 65. CHINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      67. TABLE 66. CHINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      68. TABLE 67. INDIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      69. TABLE 68. INDIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      70. TABLE 69. INDIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      71. TABLE 70. INDIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      72. TABLE 71. INDIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      73. TABLE 72. JAPAN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      74. TABLE 73. JAPAN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      75. TABLE 74. JAPAN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      76. TABLE 75. JAPAN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      77. TABLE 76. JAPAN MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      78. TABLE 77. SOUTH KOREA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      79. TABLE 78. SOUTH KOREA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      80. TABLE 79. SOUTH KOREA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      81. TABLE 80. SOUTH KOREA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      82. TABLE 81. SOUTH KOREA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      83. TABLE 82. MALAYSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      84. TABLE 83. MALAYSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      85. TABLE 84. MALAYSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      86. TABLE 85. MALAYSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      87. TABLE 86. MALAYSIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      88. TABLE 87. THAILAND MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      89. TABLE 88. THAILAND MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      90. TABLE 89. THAILAND MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      91. TABLE 90. THAILAND MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      92. TABLE 91. THAILAND MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      93. TABLE 92. INDONESIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      94. TABLE 93. INDONESIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      95. TABLE 94. INDONESIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      96. TABLE 95. INDONESIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      97. TABLE 96. INDONESIA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      98. TABLE 97. REST OF APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      99. TABLE 98. REST OF APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      100. TABLE 99. REST OF APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      101. TABLE 100. REST OF APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      102. TABLE 101. REST OF APAC MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      103. TABLE 102. SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      104. TABLE 103. SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      105. TABLE 104. SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      106. TABLE 105. SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      107. TABLE 106. SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      108. TABLE 107. BRAZIL MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      109. TABLE 108. BRAZIL MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      110. TABLE 109. BRAZIL MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      111. TABLE 110. BRAZIL MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      112. TABLE 111. BRAZIL MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      113. TABLE 112. MEXICO MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      114. TABLE 113. MEXICO MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      115. TABLE 114. MEXICO MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      116. TABLE 115. MEXICO MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      117. TABLE 116. MEXICO MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      118. TABLE 117. ARGENTINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      119. TABLE 118. ARGENTINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      120. TABLE 119. ARGENTINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      121. TABLE 120. ARGENTINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      122. TABLE 121. ARGENTINA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      123. TABLE 122. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      124. TABLE 123. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      125. TABLE 124. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      126. TABLE 125. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      127. TABLE 126. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      128. TABLE 127. MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      129. TABLE 128. MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      130. TABLE 129. MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      131. TABLE 130. MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      132. TABLE 131. MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      133. TABLE 132. GCC COUNTRIES MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      134. TABLE 133. GCC COUNTRIES MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      135. TABLE 134. GCC COUNTRIES MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      136. TABLE 135. GCC COUNTRIES MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      137. TABLE 136. GCC COUNTRIES MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      138. TABLE 137. SOUTH AFRICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      139. TABLE 138. SOUTH AFRICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      140. TABLE 139. SOUTH AFRICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      141. TABLE 140. SOUTH AFRICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      142. TABLE 141. SOUTH AFRICA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      143. TABLE 142. REST OF MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD BILLIONS) 
      144. TABLE 143. REST OF MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS) 
      145. TABLE 144. REST OF MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY DISTRIBUTION CHANNEL, 2019-2035 (USD BILLIONS) 
      146. TABLE 145. REST OF MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY FORMULATION, 2019-2035 (USD BILLIONS) 
      147. TABLE 146. REST OF MEA MEDICAL CANNABIS MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD BILLIONS) 
      148. TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL 
      149. TABLE 148. ACQUISITION/PARTNERSHIP  LIST OF FIGURES
      150. FIGURE 1. MARKET SYNOPSIS 
      151. FIGURE 2. NORTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS 
      152. FIGURE 3. US MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      153. FIGURE 4. US MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      154. FIGURE 5. US MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      155. FIGURE 6. US MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      156. FIGURE 7. US MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      157. FIGURE 8. CANADA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      158. FIGURE 9. CANADA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      159. FIGURE 10. CANADA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      160. FIGURE 11. CANADA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      161. FIGURE 12. CANADA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      162. FIGURE 13. EUROPE MEDICAL CANNABIS MARKET ANALYSIS 
      163. FIGURE 14. GERMANY MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      164. FIGURE 15. GERMANY MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      165. FIGURE 16. GERMANY MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      166. FIGURE 17. GERMANY MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      167. FIGURE 18. GERMANY MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      168. FIGURE 19. UK MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      169. FIGURE 20. UK MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      170. FIGURE 21. UK MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      171. FIGURE 22. UK MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      172. FIGURE 23. UK MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      173. FIGURE 24. FRANCE MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      174. FIGURE 25. FRANCE MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      175. FIGURE 26. FRANCE MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      176. FIGURE 27. FRANCE MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      177. FIGURE 28. FRANCE MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      178. FIGURE 29. RUSSIA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      179. FIGURE 30. RUSSIA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      180. FIGURE 31. RUSSIA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      181. FIGURE 32. RUSSIA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      182. FIGURE 33. RUSSIA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      183. FIGURE 34. ITALY MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      184. FIGURE 35. ITALY MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      185. FIGURE 36. ITALY MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      186. FIGURE 37. ITALY MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      187. FIGURE 38. ITALY MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      188. FIGURE 39. SPAIN MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      189. FIGURE 40. SPAIN MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      190. FIGURE 41. SPAIN MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      191. FIGURE 42. SPAIN MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      192. FIGURE 43. SPAIN MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      193. FIGURE 44. REST OF EUROPE MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      194. FIGURE 45. REST OF EUROPE MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      195. FIGURE 46. REST OF EUROPE MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      196. FIGURE 47. REST OF EUROPE MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      197. FIGURE 48. REST OF EUROPE MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      198. FIGURE 49. APAC MEDICAL CANNABIS MARKET ANALYSIS 
      199. FIGURE 50. CHINA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      200. FIGURE 51. CHINA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      201. FIGURE 52. CHINA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      202. FIGURE 53. CHINA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      203. FIGURE 54. CHINA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      204. FIGURE 55. INDIA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      205. FIGURE 56. INDIA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      206. FIGURE 57. INDIA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      207. FIGURE 58. INDIA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      208. FIGURE 59. INDIA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      209. FIGURE 60. JAPAN MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      210. FIGURE 61. JAPAN MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      211. FIGURE 62. JAPAN MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      212. FIGURE 63. JAPAN MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      213. FIGURE 64. JAPAN MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      214. FIGURE 65. SOUTH KOREA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      215. FIGURE 66. SOUTH KOREA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      216. FIGURE 67. SOUTH KOREA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      217. FIGURE 68. SOUTH KOREA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      218. FIGURE 69. SOUTH KOREA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      219. FIGURE 70. MALAYSIA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      220. FIGURE 71. MALAYSIA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      221. FIGURE 72. MALAYSIA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      222. FIGURE 73. MALAYSIA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      223. FIGURE 74. MALAYSIA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      224. FIGURE 75. THAILAND MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      225. FIGURE 76. THAILAND MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      226. FIGURE 77. THAILAND MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      227. FIGURE 78. THAILAND MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      228. FIGURE 79. THAILAND MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      229. FIGURE 80. INDONESIA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      230. FIGURE 81. INDONESIA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      231. FIGURE 82. INDONESIA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      232. FIGURE 83. INDONESIA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      233. FIGURE 84. INDONESIA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      234. FIGURE 85. REST OF APAC MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      235. FIGURE 86. REST OF APAC MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      236. FIGURE 87. REST OF APAC MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      237. FIGURE 88. REST OF APAC MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      238. FIGURE 89. REST OF APAC MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      239. FIGURE 90. SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS 
      240. FIGURE 91. BRAZIL MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      241. FIGURE 92. BRAZIL MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      242. FIGURE 93. BRAZIL MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      243. FIGURE 94. BRAZIL MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      244. FIGURE 95. BRAZIL MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      245. FIGURE 96. MEXICO MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      246. FIGURE 97. MEXICO MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      247. FIGURE 98. MEXICO MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      248. FIGURE 99. MEXICO MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      249. FIGURE 100. MEXICO MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      250. FIGURE 101. ARGENTINA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      251. FIGURE 102. ARGENTINA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      252. FIGURE 103. ARGENTINA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      253. FIGURE 104. ARGENTINA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      254. FIGURE 105. ARGENTINA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      255. FIGURE 106. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      256. FIGURE 107. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS BY PRODUCT TYPE 
      257. FIGURE 108. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS BY DISTRIBUTION CHANNEL 
      258. FIGURE 109. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS BY FORMULATION 
      259. FIGURE 110. REST OF SOUTH AMERICA MEDICAL CANNABIS MARKET ANALYSIS BY REGIONAL 
      260. FIGURE 111. MEA MEDICAL CANNABIS MARKET ANALYSIS 
      261. FIGURE 112. GCC COUNTRIES MEDICAL CANNABIS MARKET ANALYSIS BY APPLICATION 
      262. FIGURE 113. GCC COUNTRIE"

    Medical Cannabis Market Segmentation

     

     

     

    Medical Cannabis Market By Application (USD Billion, 2019-2035)

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

     

    Medical Cannabis Market By Product Type (USD Billion, 2019-2035)

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

     

    Medical Cannabis Market By Distribution Channel (USD Billion, 2019-2035)

    Pharmacies

    Online Stores

    Dispensaries

     

    Medical Cannabis Market By Formulation (USD Billion, 2019-2035)

    Cannabinoid-Based

    Herbal-Based

    Synthetic

     

    Medical Cannabis Market By Regional (USD Billion, 2019-2035)

    North America

    Europe

    South America

    Asia Pacific

    Middle East and Africa

     

    Medical Cannabis Market Regional Outlook (USD Billion, 2019-2035)

     

     

    North America Outlook (USD Billion, 2019-2035)

    North America Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    North America Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    North America Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    North America Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    North America Medical Cannabis Market by Regional Type

    US

    Canada

    US Outlook (USD Billion, 2019-2035)

    US Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    US Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    US Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    US Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    CANADA Outlook (USD Billion, 2019-2035)

    CANADA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    CANADA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    CANADA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    CANADA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    Europe Outlook (USD Billion, 2019-2035)

    Europe Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    Europe Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    Europe Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    Europe Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    Europe Medical Cannabis Market by Regional Type

    Germany

    UK

    France

    Russia

    Italy

    Spain

    Rest of Europe

    GERMANY Outlook (USD Billion, 2019-2035)

    GERMANY Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    GERMANY Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    GERMANY Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    GERMANY Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    UK Outlook (USD Billion, 2019-2035)

    UK Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    UK Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    UK Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    UK Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    FRANCE Outlook (USD Billion, 2019-2035)

    FRANCE Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    FRANCE Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    FRANCE Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    FRANCE Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    RUSSIA Outlook (USD Billion, 2019-2035)

    RUSSIA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    RUSSIA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    RUSSIA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    RUSSIA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    ITALY Outlook (USD Billion, 2019-2035)

    ITALY Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    ITALY Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    ITALY Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    ITALY Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    SPAIN Outlook (USD Billion, 2019-2035)

    SPAIN Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    SPAIN Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    SPAIN Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    SPAIN Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    REST OF EUROPE Outlook (USD Billion, 2019-2035)

    REST OF EUROPE Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    REST OF EUROPE Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    REST OF EUROPE Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    REST OF EUROPE Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    APAC Outlook (USD Billion, 2019-2035)

    APAC Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    APAC Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    APAC Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    APAC Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    APAC Medical Cannabis Market by Regional Type

    China

    India

    Japan

    South Korea

    Malaysia

    Thailand

    Indonesia

    Rest of APAC

    CHINA Outlook (USD Billion, 2019-2035)

    CHINA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    CHINA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    CHINA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    CHINA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    INDIA Outlook (USD Billion, 2019-2035)

    INDIA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    INDIA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    INDIA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    INDIA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    JAPAN Outlook (USD Billion, 2019-2035)

    JAPAN Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    JAPAN Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    JAPAN Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    JAPAN Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    SOUTH KOREA Outlook (USD Billion, 2019-2035)

    SOUTH KOREA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    SOUTH KOREA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    SOUTH KOREA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    SOUTH KOREA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    MALAYSIA Outlook (USD Billion, 2019-2035)

    MALAYSIA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    MALAYSIA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    MALAYSIA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    MALAYSIA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    THAILAND Outlook (USD Billion, 2019-2035)

    THAILAND Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    THAILAND Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    THAILAND Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    THAILAND Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    INDONESIA Outlook (USD Billion, 2019-2035)

    INDONESIA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    INDONESIA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    INDONESIA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    INDONESIA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    REST OF APAC Outlook (USD Billion, 2019-2035)

    REST OF APAC Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    REST OF APAC Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    REST OF APAC Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    REST OF APAC Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    South America Outlook (USD Billion, 2019-2035)

    South America Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    South America Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    South America Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    South America Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    South America Medical Cannabis Market by Regional Type

    Brazil

    Mexico

    Argentina

    Rest of South America

    BRAZIL Outlook (USD Billion, 2019-2035)

    BRAZIL Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    BRAZIL Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    BRAZIL Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    BRAZIL Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    MEXICO Outlook (USD Billion, 2019-2035)

    MEXICO Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    MEXICO Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    MEXICO Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    MEXICO Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    ARGENTINA Outlook (USD Billion, 2019-2035)

    ARGENTINA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    ARGENTINA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    ARGENTINA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    ARGENTINA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

    REST OF SOUTH AMERICA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    REST OF SOUTH AMERICA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    REST OF SOUTH AMERICA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    REST OF SOUTH AMERICA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    MEA Outlook (USD Billion, 2019-2035)

    MEA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    MEA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    MEA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    MEA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    MEA Medical Cannabis Market by Regional Type

    GCC Countries

    South Africa

    Rest of MEA

    GCC COUNTRIES Outlook (USD Billion, 2019-2035)

    GCC COUNTRIES Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    GCC COUNTRIES Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    GCC COUNTRIES Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    GCC COUNTRIES Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    SOUTH AFRICA Outlook (USD Billion, 2019-2035)

    SOUTH AFRICA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    SOUTH AFRICA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    SOUTH AFRICA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    SOUTH AFRICA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

    REST OF MEA Outlook (USD Billion, 2019-2035)

    REST OF MEA Medical Cannabis Market by Application Type

    Pain Management

    Neurological Disorders

    Cancer Treatment

    Mental Health Disorders

    Inflammatory Conditions

    REST OF MEA Medical Cannabis Market by Product Type

    Flower

    Oils

    Tinctures

    Edibles

    Topicals

    REST OF MEA Medical Cannabis Market by Distribution Channel Type

    Pharmacies

    Online Stores

    Dispensaries

    REST OF MEA Medical Cannabis Market by Formulation Type

    Cannabinoid-Based

    Herbal-Based

    Synthetic

     

     

    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027